PROTHENA CORPORATION PUBLIC LIMITED COMPANY Capital Expenditures
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Capital Expenditures of $110.00 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Cash Flow
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2013-05-15
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY payments to acquire property, plant, and equipment for the quarter ending 2013-03-31 was $110.00K, a 19.71% decline year-over-year.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY payments to acquire property, plant, and equipment for the quarter ending 2012-03-31 was $137.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month |
|---|---|
| 2013-03-31 | $110.00K 10-Q · filed 2013-05-15 |
| 2012-03-31 | $137.00K 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |